|
ASMB | Assembly Biosciences, Inc. |
|
|
ASMB | Assembly Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.10 |
| Leverage | 23.88% |
| Market Cap | $ 1.8B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -38.4m |
| Margin | -91.79% |
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.